Pharmaceutical prototyping lab floor with CNC machines and cleanroom equipment under industrial lighting
System Active
Cleanroom-Grade · ISO Class 7

From molecule
to mold.
Fourteen days.

Pill geometry, blister pack tooling, delivery device ergonomics — all under one cleanroom roof. Fifty dosage-form variants. One submission-ready package.

Scroll
Oral Solid Dosage
Blister Pack Tooling
Auto-Injector Devices
Inhaler Cartridges
Transdermal Patches
Prefilled Syringes
510(k) Ready
Phase II Compliant
ISO Class 7 Cleanroom
CNC Precision Milling
CAD-to-Physical
14-Day Turnaround
Oral Solid Dosage
Blister Pack Tooling
Auto-Injector Devices
Inhaler Cartridges
Transdermal Patches
Prefilled Syringes
510(k) Ready
Phase II Compliant
ISO Class 7 Cleanroom
CNC Precision Milling
CAD-to-Physical
14-Day Turnaround
Manufacturing Floor — Live View

Active
Project Grid

089
Carvedilol ER Tablet
Beta Blocker
Oral Solid
Phase II
14 d
7 iter
100%
Complete
091
Semaglutide PFS
GLP-1 Agonist
Injectable Device
Phase I
11 d
12 iter
78%
Active
094
Budesonide DPI
Corticosteroid
Inhaler Cartridge
Commercial
14 d
9 iter
52%
Active
097
Ozanimod Capsule
S1P Receptor
Oral Solid
Phase II
7 d
4 iter
91%
QC Gate
099
Adalimumab Auto-Inj
mAb Biologic
Auto-Injector
Pre-Clinical
14 d
18 iter
34%
Active
102
Fentanyl TDS
Opioid Analgesic
Transdermal Patch
Phase I
14 d
6 iter
0%
Pending
Data refreshes every 15 minutes · Floor timestamp: 05:14:32 UTC
Case Studies — Gate-by-Gate

Every project,
every gate.

The Brief

Helix needed 50 dosage-form variants of a 1000mg extended-release metformin tablet across three geometric profiles — oval, biconvex round, and caplet — for a Phase II bioequivalence study. Submission deadline was 16 days from brief.

The Constraint

Hydroxypropyl methylcellulose matrix required precision layering at ±2μm tolerance. Standard tooling was unavailable; custom punch geometry had to be machined in-house within 48 hours of brief approval.

Prototyping Sequence
CAD cross-section render of pharmaceutical tablet geometry on computer screen
Gate 1 — Day 1
CAD Render

Three-geometry CAD models with cross-section tolerances defined.

Outcome

50 variants delivered on Day 14. All three geometries passed dissolution testing first pass. Zero QC failures. Regulatory package submitted Day 16.

The Brief

Kinetic needed a non-functional ergonomic prototype of a single-use auto-injector for a 40mg/0.4mL adalimumab biosimilar. The device had to survive a 510(k) human factors submission review including a 180-day shelf-life simulated aging test.

The Constraint

Six-component assembly: outer shell, needle shield, plunger, spring, window panel, and labeling substrate. Each component required separate tooling. Spring force simulation had to match ±0.5N of the reference-listed device.

Prototyping Sequence
Auto-injector device CAD model exploded view on engineering workstation
Gate 1 — Day 1
Device CAD

Six-component exploded assembly with tolerances for human factors.

Outcome

All six tooling sets completed by Day 8. First full assembly on Day 11. Human factors study passed with 97% first-attempt activation rate. 510(k) submission accepted without major deficiency letter.

The Brief

Apex was 6 weeks from a commercial launch when their incumbent CMO failed a critical dimensional audit on the inhaler mouthpiece. They needed a fully functional DPI prototype with blister pack cartridge tooling that could pass an FDA Device Listing inspection.

The Constraint

Mouthpiece airflow geometry was proprietary — reverse-engineered from the existing device using CT scanning. Blister foil tooling required 96-cavity precision at 0.1mm registration tolerance. Emergency 72-hour sprint for first prototype.

Prototyping Sequence
CT scan cross-section of inhaler device showing internal airflow geometry
Gate 1 — Day 0.5
CT Scan

CT reconstruction of reference device — mouthpiece geometry extracted.

Outcome

First mouthpiece prototype delivered in 68 hours. Blister tooling completed Day 7. Full functional DPI system with 10-blister cartridge cleared FDA Device Listing inspection on Day 14. Launch timeline preserved.

Prototype Categories

What we
build here.

Turnaround
14 d

Oral Solid Dosage

Geometries12 standard + custom
Min Tablet Wt50mg
Max Tablet Wt2,000mg
CoatingFilm, enteric, sugar
Release ProfileIR, ER, DR, pulsatile
Tooling Lead48 hours

Includes blister pack and bottle packaging tooling

Turnaround
14 d

Injectable Devices

Device TypesPFS, cartridge, vial
Volume Range0.1mL – 10mL
Needle Gauge18G – 32G
Fill MediaAqueous, oil, suspension
ClosureRubber, plastic, combo
HF TestingIn-house panel ready

Functional and non-functional prototypes available

Turnaround
14 d

Auto-Injectors

ComponentsUp to 12-part assembly
Spring Force±0.5N reference match
Needle Length4mm – 16mm
ActivationCap-off, button, dual-step
MaterialABS, PC, TPE, stainless
510(k) ReadyHF + aging data included

510(k) human factors study package included

Turnaround
14 d

Inhaler Systems

TypesMDI, DPI, soft mist
ActuatorCustom geometry CNC
Cartridge4 – 120 blister cavities
Registration±0.1mm tolerance
Airflow TestCascade impactor ready
Dose CounterMechanical + electronic

CT reverse-engineering available for reformulations

Turnaround
14 d

Transdermal

Patch Area5cm² – 80cm²
MembraneRate-controlled, matrix
AdhesiveAcrylic, silicone, PIB
LinerSiliconized polyester
Release24h, 48h, 72h, 7-day
Die CutCustom shapes, pouching

In-vitro permeation testing available on-site

Scroll to explore all categories
5
Prototype Categories
Oral to transdermal
72h
Emergency Sprint
First prototype guarantee
ISO 7
Cleanroom Class
All prototyping areas
100%
510(k) Pass Rate
Human factors submissions
Ready to submit your compound brief?